FDA Approves First Gene Therapy for Rare Genetic Hearing Loss
In a landmark decision, the Food and Drug Administration has approved Otarmeni, developed by Regeneron, marking the first gene therapy specifically designed to treat a ...
The post FDA Approves First Gene Therapy for Rare Genetic Hearing Loss first appeared on [your]NEWS.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
